The entire pharmaceutical industry needs to be changed. The way Big Pharma tests drugs, the way it makes drugs and the way it markets drugs all are more about profits than health. The FDA is supposed to protect us. Guess again. If the FDA didn’t learn hard enough lessons from the heparin debacle, maybe more and more investigations like this one about Cephalon, will suddenly shake the foundations of the relationship between the regulator and who it is supposed to regulate.
Doctors getting paid to tout drugs is nothing new, but some inside light was shed on the issue recently by the pharmaceutical maker Cephalon, as chronicled in The Philadelphia Daily News Friday.
http://www.philly.com/dailynews/local/84770832.html
In a settlement Cephalon had to pay $425 million in 2008 to settle a case where it illegally marketed three drugs. As part of that settlement, it had to disclose how much it had forked over to physicians to tout its medications.
On its Web site Cephalon, based in Frazer, Pa., said that it paid 936 health-care professionals, mainly doctors, more than $9.1 million last year for consulting and speaking fees. Those payments ranged from $63 to $149,900.
Cephalon had been charged with getting doctors to promote drugs for uses that don’t have Food and Drug Administration approval. That includes Actiq, a cancer pain treatment promoted to treat migraines; Gabitril, an epilepsy drug promoted for anxiety and pain; and Provigil, a medication for sleep disorders that was promoted to treat adult attention deficit disorder, depression and multiple sclerosis.
Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.
http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney
Inside Look at How Much Drug Makers Pay Doctors To Promote Their Meds
Posted on 22nd February 2010 by gjohnson in Uncategorized
Cephalon marketing methods, corruption in drug industry, FDA incompetency, FDA problems, FDA recall heparin
No comments yet.
Leave a comment
- FDA Finds Food Safety Violations At Two Iowa Farms That Recalled Eggs
- Two Years After Heparin Deaths, Ways To Keep Tabs On The Drug Suppy Chain
- New York Times Editorial Calls For Senate Action On Food Safety Bill
- Egg Recall May Lead To Food Safety Reform
- With 550 Millions Eggs Recalled, FDA Head Calls For Help
- Baxter Tries To Keep Some Information About 2008 Heparin Tragedy Under Seal
- FDA Expresses Doubts About Approving Cymbalta To Treat Pain
- Jerry Brown To ‘Bounce House’ Makers: Get The Lead Out
- American’s Mistrust Drugs Made Outside The U.S., But Most Have Ingredients That Are
- Millions Of Frozen Mice, Dinner For Snakes, Recalled After Salmonella Outbreak
- Liane: Here is an article regarding the decreased potency of Heparin:http://www.newsinferno .com/archives/13187
- vtwin: I have recently stayed in a hospital where I was administeredHeparin. Are the issues resolved?Martin
- David W. Zoll: Gordon, this is not accurate. You should talk to Don Nolan and correct this entry. Most of the death...
- Imjtodd007: Could the heparin contamination cause a condition simular to Chronic Inflammatory Demyelinating...
- Lmora's blog: Just yesterday, I went down to the courthouse for an order to pull my husbands Medical Records, When I...
Sorry. No data so far.
Archives
- September 2010 (1)
- August 2010 (9)
- July 2010 (1)
- June 2010 (2)
- May 2010 (8)
- April 2010 (11)
- March 2010 (5)
- February 2010 (6)
- December 2009 (1)
- October 2009 (3)
- September 2009 (5)
- July 2009 (3)
- May 2009 (4)
- April 2009 (6)
- March 2009 (15)
- February 2009 (4)
- January 2009 (1)
- December 2008 (3)
- November 2008 (2)
- October 2008 (6)
- September 2008 (3)
- August 2008 (3)
- July 2008 (4)
- May 2008 (7)
- April 2008 (16)
- March 2008 (7)
- February 2008 (5)